Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism-Reference-Cited by-同舟云学术

Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism

Published:2021-07 Issue:8 Volume:31 Page:2490-2506
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Srivastava Rai Ajit K.,Hurley Timothy R.,Oniciu Daniela^ORCID,Adeli Khosrow,Newton Roger S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference89 articles.

1. Regulation of low density lipoprotein receptor gene expression in HepG2 and Caco2 cells by palmitate, oleate, and 25-hydroxycholesterol;Srivastava;J Lipid Res,1995

2. Identification and validation of a selective small molecule inhibitor targeting the diacylglycerol acyltransferase 2 activity;Kim;Biol Pharm Bull,2013

3. A small-molecule screening strategy to identify suppressors of statin myopathy;Wagner;ACS Chem Biol,2011

4. Screen for small molecules increasing the mitochondrial membrane potential;Montague;J Biomol Screen,2014

5. Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene;Srivastava;J Lipid Res,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression and Role of PDK4 on Childhood Dyslipidemia and Lipid Metabolism in Hyperlipidemic Mice;Hormone and Metabolic Research;2023-12-14

2. New opportunities in the management and treatment of refractory hypercholesterolemia using in vivo CRISPR-mediated genome/base editing;Nutrition, Metabolism and Cardiovascular Diseases;2023-12

3. A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD;Cells;2023-06-16

4. Corrigendum to “Discovery of analogues of non-β oxidizable long-chain dicarboxylic fatty acids as dual inhibitors of fatty acids and cholesterol synthesis: Efficacy of lead compound in hyperlipidemic hamsters reveals novel mechanism” [Nutr Metabol Cardiovasc Dis 31 (2021) 2490–2703];Nutrition, Metabolism and Cardiovascular Diseases;2022-01